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ABSTRACT 
Objective: Hepatitis C virus (HCV) is the cause of hepatitis C in human. A hepatitis C infection does not show any noticeable symptoms in the very 
early stages of the infection, but a chronic infection can ultimately lead to cirrhosis. The chronic condition results in liver failure or cancer. Protein-
Protein interactions play a vital role in the pathogenesis of any pathogen. Protein-Protein interactions maps designed and created in this research 
provide accurate and valuable resource for better understanding of the pathogenicity pathways of Hepatitis C Virus. The objective of the study was 
to predict the epitope against non-structural protein NS (5a) of Hepatitis C Virus which could be used as suitable vaccine candidate against Hepatitis 
C virus infections.  
Methods: A specific protein-protein interaction is selected on the basis of its significance in the pathway leading to replication of Hepatitis C 
genome i. e. Interaction between Hepatitis C Nonstructural protein 5A (NS5A) with sh3 domain of Fyn tyrosine protein kinase. Epitopes was 
predicted and screened by using various bioinformatics tools. Each of the predicted structure was docked with MHC Class I and class II molecules 
using PatchDock and FireDock. 
Results: The MVGLNSYRI epitope was selected on the basis of half life of dissociation and binding score. The average score of half-life of 
disassociation (t1/2) for MVGLNSYRI was 20 hrs, which is the greater than the other epitopes. Structure based modeling of epitopes was done and 
further the energy was optimized. Then after that the binding score was calculated, which was again best in case of MVGLNSYRI. 
Conclusion: These findings conclude that the designed protein-protein interaction maps and predicted epitopes can be of great use in the wet 
laboratory formulations of vaccines against Hepatitis C Virus. 
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INTRODUCTION 
Hepatitis C virus (HCV) is the cause of hepatitis C in humans. A 
hepatitis C infection does not show any noticeable symptoms in the 
very early stages of the infection, but a chronic infection can 
ultimately lead to cirrhosis. The chronic condition results in liver 
failure or cancer. Hepatitis C spread mostly through blood to blood 
contact, unsterilized equipment used for intravenous drug transfer. 
The number of people affected by hepatitis C infection worldwide is 
approximately 200 million per annum which is responsible for 
hundreds of thousands of deaths each year.  
Hepatitis C virus infects only humans and chimpanzees. The 
knowledge about hepatitis C infection was first reported in the year 
1989[1]. It belongs to the genus Hepacivirus and is a member of 
family flaviviridae [2]. It is an enveloped positive sense single 
stranded RNA virus with approximately 55-65 nm. Despite the 
discovery of HCV over 15 years ago, knowledge of the HCV lifecycle 
has been limited by inability to grow the virus in cell culture, as well 
as by the lack of small-animal models of HCV infection [3].  
HCV has an RNA genome which consists of 9600 nucleotide bases. It 
consists of UTRs at 5’ and 3’ ends of the RNA. The genome contains a 
non-coding region (5’-3’) and a coding region. HCV genome comes 
with a high genetic variability caused due to the mutations that 
happens frequently during the viral replication. These mutations 
vary in different genomic regions of HCV [4]. Structural proteins of 
HCV are core protein (E1 and E2) which are primarily present in the 
coding region of the genome and non-structural proteins (NS2, NS3, 
NS4, NS4A, NS4B, NS5, NS5A, NS5B) [2].  
The proteins encoded by Hepatitis C genome (structural and non-
structural proteins) are primarily responsible for the pathogenesis 
of Hepatitis C virus. The Hepatitis C viral proteins interact with the 
proteins present in the human host cells and generate certain 
signaling pathways which in turn regulate the replication of 
Hepatitis C genome and its survival in human cells. The no-
structural NS1 protein is a hydrophobic transmembrane protein 
which basically form hydrophilic pores and there by regulating the 
permeability of the membrane for the propagation of viral assembly 
and release of viral particles to increase infectivity, NS2 protein 
works as to attract the envelope proteins to the assembly site and 
favours viral assembly, NS3 has helicase as well as protease activity. 
It plays a central role in the process of viral replication. It has its 
major role in unwinding of viral RNA alone and in complex with 
NS4A, NS4A functions as cofactor for proper working of NS3 protein 
for increased enzymatic activities. NS4A also forms complex with 
NS4B and NS5A to facilitate viral replication on the endoplasmic 
reticulum membrane, NS4B is associated with NS5B so as to modify 
its polymerase activity, thus showing its role in carcinogenesis. 
NS4B favours viral replication as it is involved in the formation of 
the membranous structure which acts as a platform for viral 
replication to happen, NS5A is necessary for the viral replication as 
well as viral assembly, NS5B works as RNA dependent RNA 
polymerase [5].  
The overall pathogenicity of Hepatitis C virus depends upon the 
interactions between the proteins coded by its genome and their 
interactions with the human proteins which together result in 
manipulations to the originally occurring cellular processes and the 
pathways, thereby increasing pathogenicity. Thus in order to further 
known the pathogenicity pathways, various protein-protein 
interactions can be extracted and used in the construction of 
pathways. Protein–protein interaction maps provide information 
about the proteins which are highly involved in the viral replication 
and life cycle. Thus, maps provide a more easy and illustrative way 
of acquiring knowledge about important interactions between 
different proteins which are involved in the viral replication.  
By studying the interaction map for Hepatitis C protein NS5A 
various assertions can be made supporting the fact that it is the 
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protein which is highly involved in the viral replication. Here the 
main emphasis is on the functioning and regulation of NS5A as it has 
key roles in various viral processes and thus it emerges as a 
potential target for vaccine and drug designing using bioinformatics 
approach. 
MATERIALS AND METHODS 
Extraction of Protein-Protein interactions Data 
Extraction of Protein-protein interactions between different 
proteins present in Hepatitis C Virus and proteins present in human. 
For the extraction of protein-protein interaction data “HCVpro” 
database is utilized.  
HCVpro is an online database for the protein-protein interactions 
between Hepatitis C Viral proteins and human proteins. Highly 
specific protein interactions extracted in a strain specific manner. 
HCVpro provide absolute interaction data containing the PubMed 
identifiers for each interaction. 
Preparation of protein specific interaction list 
The enormous raw form of protein-protein interactions was 
extracted from the “HCVpro” database and processed manually in a 
protein specific manner. Interactions of each of the Hepatitis C 
proteins are listed separately. 
Analysis of interactions maps 
Detailed analysis of protein-protein interaction maps was done by 
studying different interactions between Hepatitis C proteins and human 
proteins. A specific protein-protein interaction is selected on the basis of 
its significance in the pathway leading to replication of Hepatitis C 
genome i. e.  
Interaction between Hepatitis C Nonstructural protein 5A (NS5A) with 
sh3 domain of Fyn tyrosine protein kinase 
Analysis of protein-protein interaction 
Selected protein-protein interaction is studied to find out type of 
interaction between NS5A and Fyn tyrosine protein kinase by 
mining of PubMed research articles. This interaction provided 
insights that NS5A can be targeted so as to develop the potential 
vaccine against Hepatitis C Virus. 
Prediction of T-cell Epitopes for target protein 
Fasta sequence of the protein NS5A is used to predict class I and 
Class II MHC binding peptides by using “Propred” for MHC-II [6] and 
“Propred-I” for MHC-I [7]. Propred is an online server for the 
prediction of MHC II binding peptides for 51 alleles whereas 
Propred-I is an online server for the prediction of MHC I binding 
peptides for 47 alleles. 
Virtual Screening 
In this step, we screened the promiscuous MHC binders separately 
for both the class of MHC molecules. Predicted T-cell epitopes were 
screened on the basis of total average score and number of alleles. 
We obtained 6 peptide sequences (epitopes) after virtual screening 
which were the binders to both MHC Class-I and MHC Class-II 
molecule. These were, (DEITFMVGL;  WRGDGVMST;  VVILDSFEP;  
MVGLNSYRI;  DVSVLTSML;  TRCSCGATI) [8]. 
Tertiary structure prediction for epitopes 
Structure prediction is done by “PepFold” which is an online peptide 
structure prediction server. It uses four consecutive residues and 
predicts their conformations using greedy algorithm coupled with 
coarse grained force field. Only one conformation (model) is selected 
for each peptide on the basis of lowest sOPEP (OPEP-Optimized 
Potential for Efficient Structure Prediction) energy.  
Docking using patch dock and fire dock 
Each of the predicted structure was docked with MHC Class I and 
class II molecules using PatchDock and FireDock. PatchDock 
provides best binding peptide using the best binding score for each 
peptide. FireDock refine the PatchDock result and gives the best 
binding peptide using Global energy of each docking [9]. Best 
epitopes having the lowest global energy and binding score were 
selected as potential high affinity binding epitope. 
Calculation of Isoelectric point (pI value) and half-life of 
dissociation of selected epitopes 
Isoelectric point and molecular weight of the epitopes was 
calculated using ExPASy tool online. Lowest Pi value epitopes were 
selected. 
 
Table 1: Various Protein-protein interactions, corresponding gene, Entrez gene IDs, Human protein names and HCVpro interactions 
identifiers NS5A sequence of 452 amino acids is used to predict MHC Class I and Class II binding peptides. 
HCVpro ID  Molecule A  Molecule B Gene Symbols  Molecule B Gene ID  PMID  Experimental Evidence (PSI-MI Term ID)  
hcv0453  NS5A  EIF2AK2  5610  9143277  Two Hybrid Test (MI: 0018)  
hcv0477  NS5A  FYN  2534  14993658  Affinity Chromatography (MI: 0004)  
 
Table 2: Docking results of Predicted Peptides with MHC molecule using PatchDock 
S. No.  EPITOPES  MHC-Molecule pI Value Binding Score Global Energy Half life 
1.  DEITFMVGL  I II 3.67 10488 9722 -1.50 1.1 hr. 
2. TRCSCGATI I  7.75 8298  215.97 7.2 hrs. 
3. DVSVLTSML I  3.80 9198  0.84 1.1 hrs. 
4. MVGLNSYRI  I II 8.50 10704 9918 -45.23 20 hrs. 
5. VVILDSFEP II  3.67 8518  2.27 100 hrs. 
6. WRGDGVMST II  5.84 7716  14.54 2.8 hrs. 
 
Predicted structures of all 6 epitopes namely tertiary structures of 
MHC Class I (PDB ID:  1HSA) and MHC Class II (PDB ID:  1DLH) were 
retrieved from PDB (Figure 1). Also the peptide binding to the MHC 
class I and MHC class II molecule was observed (Figure 2). The 
peptides (shown in blue color) predicted a have very high affinity for 
the MHC-I and MHC-II modeled with the help of Gromacs server. The 
highest binder peptide MVGLNSYRI is derived from the HCV. 
RESULTS  
HCVpro database is used to retrieve protein-protein interaction data 
of Hepatitis C Virus in a raw form. The raw data is segregated 
specifically for each HCV protein in a tabular form having Various 
Protein- protein interactions, corresponding gene, Entrez gene IDs, 
Human protein names and HCVpro interactions identifiers (Table 1). 
Docking results obtained for predicted peptides with MHC molecule 
using PatchDock are shown in Table 2. 
Docking result of MHC-1 and MHC-II with most valid epitopes:   
We performed the docking of all the six peptide structures 
separately each with MHC Class-I (PDB ID:  1HSA) and MHC Class-II 
(PDB ID:  1DLH) molecule using an online docking tool named as 
Patch Dock. For the best result the docking score should be 
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maximum, we found that the docking of the peptide sequence 
(MVGLNSYRI) with MHC Class-I (PDB ID:  1HSA) showed the top 
most score of 10704 as compared to other peptide sequences. In 
second case, the docking of peptide sequence (MVGLNSYRI) with the 
MHC Class-II (PDB ID:  1DLH) again showed the highest score of 
9918 as compared to other peptide sequence. 
DISCUSSION 
Biological processes are mainly controlled by various mechanisms 
such as signal transduction through protein-protein interactions and 
other protein modifications. The construction of major pathogenicity 
island regulatory pathways in hepatitis C virus subtype NS5A helped 
here in acquiring the understanding of basic regulation and 
mechanism of survival in host cells. 
 
 
Fig. 1: Predicted structures of all 6 epitopes. Tertiary structures 
of MHC Class I (PDB ID:  1HSA) and MHC Class II (PDB ID:  1DLH) 
were retrieved from PDB. 
 
 
Fig. 2: The peptide binding to the MHC class I and MHC class II 
molecule. The peptides (shown in blue color) predicted to a 
have very high affinity for the MHC-I and MHC-II modeled with 
the help of Gromacs server. The highest binder peptide 
MVGLNSYRI is derived from the HCV. 
 
This knowledge about the mechanism of survival and regulation is 
highly necessary for the effective and efficient identification as well 
as detection and treatment of this viral infection in host. Protein-
Protein interactions between different human and HCV proteins 
provides the insights about proteins that can act as potential target 
so as to prevent the HCV chronic infection. .The NS5A is necessary 
for the viral replication as well as viral assembly. The MVGLNSYRI 
epitope was selected on the basis of half life of dissociation and 
binding score. In case of the half life of dissociation, more the time of 
dissociation, better the candidate epitope (Kaushik et al., 2013). 
 From the table, it can be inferred that, the average score of half-life 
of disassociation (t1/2) for MVGLNSYRI is 20 hrs, which is the greater 
than the other epitopes. Structure based modeling of epitopes was 
done and further the energy was optimized. Then after that the 
binding score was calculated, which was again best in case of 
MVGLNSYRI. However, as shown in the hypothetical example of 
planning a vaccine, the discovery of suitable antigens could be a 
small part of the problem of producing an effective vaccine, but 
never the less important. The study shows that the predicted 
epitope can be developed as a potential vaccine candidate. 
CONCLUSION 
Protein-Protein interactions play a vital role in the pathogenesis of 
any pathogen. Proteins coded by the Hepatitis C Viral genome 
interact with different human proteins interfering and modulating 
the natural functioning of human proteins and other important 
factors. This promotes Hepatitis C Viral replication and production 
of large number of viral particles which infect other cells, causing 
critical antigenic condition. Protein-protein interactions maps 
designed and created in this research provides accurate and 
valuable resource for better understanding of the pathogenicity 
pathways of Hepatitis C Virus. Role of different proteins in the 
pathogenesis were interpreted using interactions present in the 
interaction maps. Nonstructural protein 5A (NS5A) is an important 
protein which is known to be highly involved in the protein-protein 
interactions during different regulatory pathways leading to the 
replication of viral genome. For the prediction of an effective vaccine 
against Hepatitis C Virus, non-structural protein 5A (NS5A) epitopes 
for MHC Class I and MHC Class II were predicted in this research. 
These epitopes show high affinity binding with MHC Class I and MHC 
Class II molecules. In contrast to these epitopes, MVGLNSYRI was 
found to be the high affinity binding epitope for MHC Class I and 
MHC Class II repectively. These findings conclude that the designed 
protein-protein interaction maps and predicted epitopes can be of 
great use in the wet laboratory formulations of vaccines against 
Hepatitis C Virus. 
CONFLICTS OF INTEREST 
Authors declare that there are no conflicts of interest. 
REFERENCES 
1. Houghton M. The long and winding road leading to the 
identification of the hepatitis C virus. J Hepat 2009;51:939-48. 
2. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos 
C, et al. Genetic organization and diversity of the hepatitis C 
virus. Proc Nat Acad Sci USA 1991;88:2451-5. 
3. Kolykhalov L, Rehak V, Riley LW. Structure and functions of 
hepatitis C virus proteins: 15 years after. Folia Microbiologica 
2006;51:665-80. 
4. Steinmann E, Penin F, Kallis S, Patel AH, Bartenschlager R, 
Pietschmann T. Hepatitis C Virus p7 protein is crucial for 
assembly and release of infectious virions. PloS Path 
2007;3:e103. 
5. Huang Y, Staschke K, De Francesco R, Tan SL. Phosphorylation 
of hepatitis C virus NS5A nonstructural protein: A new 
paradigm for phosphorylation-dependent viral RNA 
replication. Virol 2007;364:1-9.  
6. Singh H, Raghava GPS. ProPred1: prediction of promiscuous 
MHC Class-I binding sites. Bioinfo 2003;19:1009-14.  
7. Singh H, Raghava GPS. Propred: Prediction of HLA-DR binding 
sites. Bioinfo 2001;17:1236-7. 
8. Kaushik V, Singh J, Kaur R, Kumar A. In Silico peptide based 
vaccine design against non-Structural Protein 3 of Hepatitis C 
virus. Conf Proc Wilkes100-ICCS 2013:172-3. 
9. Schneidman  Duhovny D, Inbar Y, Nussinov R, Wolfson HJ. 
Patch Dock and Symm Dock: servers for rigid and symmetric 
docking. Nuc Acids Res 2005;33:W363-7. 
 
